These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2713851)
1. Characterization of a cisplatin-resistant subline of murine RIF-1 cells and reversal of drug resistance by hyperthermia. Mansouri A; Henle KJ; Benson AM; Moss AJ; Nagle WA Cancer Res; 1989 May; 49(10):2674-8. PubMed ID: 2713851 [TBL] [Abstract][Full Text] [Related]
2. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro. Shellard SA; Hosking LK; Hill BT Cancer Res; 1991 Sep; 51(17):4557-64. PubMed ID: 1873800 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin. Jain N; Lam YM; Pym J; Campling BG Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677 [TBL] [Abstract][Full Text] [Related]
4. Cross-resistance to cisplatin in cells resistant to photofrin-mediated photodynamic therapy. Moorehead RA; Armstrong SG; Wilson BC; Singh G Cancer Res; 1994 May; 54(10):2556-9. PubMed ID: 7909492 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate. Hill BT; Shellard SA; Hosking LK; Dempke WC; Fichtinger-Schepman AM; Tone T; Scanlon KJ; Whelan RD Cancer Res; 1992 Jun; 52(11):3110-8. PubMed ID: 1591724 [TBL] [Abstract][Full Text] [Related]
6. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells. Lai SL; Hwang J; Perng RP; Whang-Peng J Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042 [TBL] [Abstract][Full Text] [Related]
7. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Kasahara K; Fujiwara Y; Nishio K; Ohmori T; Sugimoto Y; Komiya K; Matsuda T; Saijo N Cancer Res; 1991 Jun; 51(12):3237-42. PubMed ID: 1645616 [TBL] [Abstract][Full Text] [Related]
8. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance. Sharp SY; Rogers PM; Kelland LR Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells. Kotoh S; Naito S; Yokomizo A; Kumazawa J; Asakuno K; Kohno K; Kuwano M Cancer Res; 1994 Jun; 54(12):3248-52. PubMed ID: 8205547 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Teicher BA; Holden SA; Kelley MJ; Shea TC; Cucchi CA; Rosowsky A; Henner WD; Frei E Cancer Res; 1987 Jan; 47(2):388-93. PubMed ID: 3539321 [TBL] [Abstract][Full Text] [Related]
11. Hyperthermic modulation of resistance to cis-diamminedichloroplatinum (II) in human larynx carcinoma cells. Beketić-Oresković L; Jaksić M; Oresković S; Osmak M Int J Hyperthermia; 1997; 13(2):205-14. PubMed ID: 9147146 [TBL] [Abstract][Full Text] [Related]
12. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Schmidt W; Chaney SG Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro. Hospers GA; Mulder NH; de Jong B; de Ley L; Uges DR; Fichtinger-Schepman AM; Scheper RJ; de Vries EG Cancer Res; 1988 Dec; 48(23):6803-7. PubMed ID: 2846161 [TBL] [Abstract][Full Text] [Related]
14. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin. Chen G; Zeller WJ; Todorov DK Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Behrens BC; Hamilton TC; Masuda H; Grotzinger KR; Whang-Peng J; Louie KG; Knutsen T; McKoy WM; Young RC; Ozols RF Cancer Res; 1987 Jan; 47(2):414-8. PubMed ID: 3539322 [TBL] [Abstract][Full Text] [Related]
16. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968 [TBL] [Abstract][Full Text] [Related]
17. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme. Wang W; Liu G; Zheng J Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556 [TBL] [Abstract][Full Text] [Related]
18. [Mechanisms for resistance and cross-resistance patterns of cisplatin-resistant tumor lines]. Tashiro T Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):509-14. PubMed ID: 2321979 [TBL] [Abstract][Full Text] [Related]
19. Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents. Begleiter A; Leith MK; McClarty G; Beenken S; Goldenberg GJ; Wright JA Cancer Res; 1988 Apr; 48(7):1727-35. PubMed ID: 3127038 [TBL] [Abstract][Full Text] [Related]
20. New approaches to the study of tumor drug resistance. Mansouri A; Henle KJ; Nutt AK; Nagle WA SAAS Bull Biochem Biotechnol; 1991 Jan; 4():13-6. PubMed ID: 1367247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]